These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 4390619)

  • 1. Comparative spasmolytic potencies of atropine sulphate and N-butyl hyoscine bromide following intravenous injection, injection into a mesenteric vein, and intraduodenal instillation.
    Bauer R; Wick H
    J Pharm Pharmacol; 1969 Oct; 21(10):706-8. PubMed ID: 4390619
    [No Abstract]   [Full Text] [Related]  

  • 2. [On the differences of effect of atropine, scopolamine and some of their quaternary derivatives after subcutaneous and enteral administration with special reference to scopolamine-n-butylbromide].
    Bauer R; Gross E; Scarselli V; Stockhaus K; Wick H
    Arzneimittelforschung; 1968 Sep; 18(9):1132-7. PubMed ID: 5755927
    [No Abstract]   [Full Text] [Related]  

  • 3. Observations on the efficacy of oral hyoscine N-butyl bromide.
    Pennefather JN; McCulloch MW; Rand MJ
    J Pharm Pharmacol; 1968 Nov; 20(11):867-72. PubMed ID: 4387495
    [No Abstract]   [Full Text] [Related]  

  • 4. Intestinal absorption, intestinal distribution, and excretion of (14C) labelled hyoscine N-butylbromide (butylscopolamine) in the rat.
    Pentikäinen P; Penttilä A; Vapaatalo H; Hackman R
    J Pharm Pharmacol; 1973 May; 25(5):371-5. PubMed ID: 4146391
    [No Abstract]   [Full Text] [Related]  

  • 5. [Cholinergic contraction of the dog urinary bladder by electrical stimulation of the n. pelvicus and the ligamenta lateralia nerves and its affection by atropine and scopolaminebutylbromide (author's transl)].
    Bauer R; Wick H
    Arzneimittelforschung; 1976; 26(7):1359-61. PubMed ID: 1036925
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The gastrointestinal absorption and the excretion of H3-butylscopolamine (hyoscine butylbromide) in man.
    Hellström K; Rosén A; Söderlund K
    Scand J Gastroenterol; 1970; 5(7):585-92. PubMed ID: 5474428
    [No Abstract]   [Full Text] [Related]  

  • 7. [Pharmacological studies of antispasmodics. III. Antispasmodic activity of 3-(di-2-thienylmethylene)-5-methyl-trans-quino-lizidinium bromide (HRS-902) on smooth muscle organs and its organ selectivity (author's transl)].
    Kubo S; Morikawa K; Matsubara I; Yamazaki M; Kato H
    Nihon Yakurigaku Zasshi; 1981 Jan; 77(1):87-98. PubMed ID: 7262709
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative study of the effects of oral and i.m. atropine and hyoscine in volunteers.
    Mirakhur RK
    Br J Anaesth; 1978 Jun; 50(6):591-8. PubMed ID: 666935
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of hyoscine and atropine on the lower oesophageal sphincter.
    Brock-Utne JG; Rubin J; McAravey R; Dow TG; Welman S; Dimopoulos GE; Moshal MG
    Anaesth Intensive Care; 1977 Aug; 5(3):223-5. PubMed ID: 19986
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hyoscine butylbromide: a useful premedicant.
    Fry EN
    Anaesthesia; 1975 Jul; 30(4):549-50. PubMed ID: 1096666
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metabolic N-oxidation of atropine, hyoscine and the corresponding nor-alkaloids by guinea-pig liver microsomal preparations.
    Phillipson JD; Handa SS; Gorrod JW
    J Pharm Pharmacol; 1976 Sep; 28(9):687-91. PubMed ID: 10391
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The relevance of the osmolarity of the instillation fluid to the effectiveness and toxicity of drugs given by the intraduodenal route--solvent drug influence on the intestinal absorption of drugs.
    Vogel G; Becker U; Ulbrich M
    Arzneimittelforschung; 1975 Jul; 25(7):1037-9. PubMed ID: 1174409
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Affinities of the protonated and non-protonated forms of hyoscine and hyoscine N-oxide for muscarinic receptors of the guinea-pig ileum and a comparison of their size in solution with that of atropine.
    Barlow RB; Winter EA
    Br J Pharmacol; 1981 Apr; 72(4):657-64. PubMed ID: 7284683
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pralidoxime mesylate absorption and heart rate response to atropine sulphate following intramuscular administration of solution mixtures.
    Holland P; Parkes DC; White RG
    Br J Clin Pharmacol; 1975 Aug; 2(4):333-8. PubMed ID: 788732
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Morphine, scopolamine, and atropine as intravenous surgical premedicants.
    Conner JT; Bellville JW; Wender R; Schehl D; Dorey F; Katz RL
    Anesth Analg; 1977; 56(5):606-14. PubMed ID: 562085
    [No Abstract]   [Full Text] [Related]  

  • 16. Anticholinergic effects and passage through the intestinal wall of N-butylhyoscine bromide.
    Pomeroy AR; Rand MJ
    J Pharm Pharmacol; 1969 Mar; 21(3):180-7. PubMed ID: 4388214
    [No Abstract]   [Full Text] [Related]  

  • 17. RESPONSES OF THE RAT URINARY BLADDER IN SITU TO DRUGS AND TO NERVE STIMULATION.
    VANOV S
    Br J Pharmacol Chemother; 1965 Apr; 24(2):591-600. PubMed ID: 14325339
    [No Abstract]   [Full Text] [Related]  

  • 18. Comparative studies on intramuscular and oral effective doses of some anticholinergic drugs.
    Möller J; Rosén A
    Acta Med Scand; 1968 Sep; 184(3):201-9. PubMed ID: 4885006
    [No Abstract]   [Full Text] [Related]  

  • 19. Large dose atropine alkaloids in the treatment of shock.
    Chen HH
    Resuscitation; 1983 Feb; 10(3):149-51. PubMed ID: 6302793
    [No Abstract]   [Full Text] [Related]  

  • 20. Sulphotransferase-dependent dehydration of atropine and scopolamine in guinea pig.
    Wada S; Shimizudani T; Yamada H; Oguri K; Yoshimura H
    Xenobiotica; 1994 Sep; 24(9):853-61. PubMed ID: 7810167
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.